Fri, May 19, 2023
Thu, May 18, 2023
Wed, May 17, 2023

David Nierengarten Reiterated (TSVT) at Buy and Held Target at $26 on, May 18th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-26-on-may-18th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Nierengarten of Wedbush, Reiterated "2seventy bio, Inc." (TSVT) at Buy and Held Target at $26 on, May 18th, 2023.

David has made no other calls on TSVT in the last 4 months.



There are 2 other peers that have a rating on TSVT. Out of the 2 peers that are also analyzing TSVT, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $28 on, Tuesday, January 24th, 2023
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $28 on, Friday, January 20th, 2023

Publication Contributing Sources